Molecular and cellular mechanisms of heparin-induced thrombocytopenias;Mecanismes moleculaires et cellulaires des thrombopenies induites par l'heparine

Hematologie

Volumn 2, Issue 4, 1996, Pages 279-286

  Amiral, Jean ^a   Wolf, Martine ^a   Vissac, Anne Marie ^a   Meyer, Dominique ^a  

^a Service d'Immunologie   (France)

Author keywords

auto antibodies; chemokines; heparin; PF4; thrombocytopenia

Indexed keywords

HEPARIN; INTERLEUKIN 8;

AUTOIMMUNITY; HUMAN; REVIEW; THROMBOCYTOPENIA;

EID: 0029797210     PISSN: 12647527     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Chong BH. Heparin-induced thrombocytopenia. Br J Haematol 1995 ; 89 : 431 -9.
2. Huisse MC, Guillin MC, Bezeaud Z, Toulemonde F, Kitzis M, Andreassian B. Heparin-associated thrombocytopenia. In vitro effects of different molecular weight heparin fractions. Thromb Res 1982 ; 27 : 485-90.
3. Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia. Blood 1986 ; 67 : 27-30.
4. Greinacher A, Michels I, Kiefel V, Mueller-Eckhardt C. A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia. Thromb Haemostasis 1991 ; 66 : 734-6.
5. Stewart MW, Etches WS, Boshkov LK, Gordon PA. Heparin-induced thrombocytopenia : an improved method of detection based on lumi-aggregometry. Br J Haematol 1995 ; 91 : 173-7.
6. Amiral J, Bridey F, Dreyfus M, Vissac AM, Fressinaud E, Meyer D. Identification of PF4 as a target for antibodies generated in heparin-induced thrombocytopenia : development of a diagnostic test. Thromb Haemostasis 1991 ; 65 : 865 (abstract).
7. Amiral J, Bridey F, Dreyfus M, Vissac AM, Fressinaud E, Wolf M, Meyer D. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin induced thrombocytopenia. Thromb Haemostasis 1992 ; 68 : 95-6.
8. Amiral J, Peynaud-Debayle E, Wolf M, Bridey F, Vissac AM, Meyer D. Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low molecular weight heparin. Am J Hemat (in press).
9. Amiral J, Meyer D. Rôle du facteur plaquettaire 4 (PF4) dans les thrombopénies induites par l'héparine. Sang Thromb Vaiss 1995; 7: 549-55.
10. Green D, Harris K, Reynolds N, Roberts M, Patterson R. Heparin immune thrombocytopenia : evidence for a heparin-platelet complex as the antigenic determinant. J Lab Clin Med 1978 ; 91 : 167-75.
11. Lynch DM, Howe SE. Heparin-associated thrombocytopenia : antibody binding specificity to platelet antigens. Blood 1985 , 66 :1176-81.
12. Gruel Y, Boizard-Boval B, Wautier JL Further evidence that alpha-granule components such as platelet factor 4 are involved in platelet-IgG-heparin interactions during heparin-associated thrombocytopenia. Thromb Haemostasis 1993 ; 70. 375
13. Greinacher A, Pötzch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C. Heparin associated thrombocytopenia : isolation of the antibody and characterization of a multi-molecular PF4-heparin complex as the major antigen. Thromb Haemostasis 1994; 71 : 247-51.
14. Kelton JG, Smith JW, Warkentin TE, Hayward CPM, Denomme GA, Horsewood P. Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to o complex of heparin and platelet factor 4. Blood 1994; 83 : 3232-9.
15. Visentin GP, Ford SE, Scott JP, Aster RH. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexes with heparin or bound to endothelial cells. J Clin Invest 1994 ; 93 : 81-8.
16. Amiral J, Bridey F, Wolf M, Boyer-Neumann C, Fressinaud E, Vissac AM, Peynaud-Debayle E, Dreyfus M, Meyer D. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin induced thrombocytopenia : a study of 44 cases. Thromb Haemostasis 1995 ; 73 . 21-8.
17. Greinacher A, Michels I, Mueller-Eckhardt C. Heparin-associated thrombocytopenia : the antibody is not heparin specific. Thromb Haemostasis 1992 ; 67 : 545-9.
18. Bock PE, Luscombe M, Marshall SE, Pepper DS, Holbrook JJ. The multiple complexes formed by the interaction of platelet factor 4 with heparin. Biochem J 1980 ; 191 : 769-76.
19. Stuckey JA, St Charles R, Edwards B. A model of the platelet factor 4 complex with heparin. Proteins 1992 ; 14 : 277-87.
20. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG. Heparin-induced thrombocytopenia in patients treated with low molecular-weight heparin or unfractionated heparin. N Engl J Med 1995 ; 332 : 1330-5.
21. Amiral J, Wolf M, Fischer AM, Boyer-Neumann C, Vissac AM, Meyer D Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin induced thrombocytopenia. Br J Haematol 1990 ; 92 : 954-9.
22. Arepally G, Poncz M, McKenzie SE, Cines D. Characterization of antibody subclass specificity and antigenic determinants in heparin-associated-thrombocytopenia (HAT). Blood 1994 ; 84 : 189a.
23. Kelton JG, Sheridan D, Santos A, Smith J, Steeves K, Smith C, Brown C, Murphy WG. Heparin induced thrombocytopenia : laboratory studies. Blood 1988 ; 72 : 925-30.
24. O'Brien JR, Etherington MD, Pashley M. Intra-platelet platelet factor 4 (IP.PF4) and the heparin-mobilisable pool of PF4 in health and atherosclerosis. Thromb Haemostasis 1984 ; 51 : 354-7
25. Home III McDK, Chao ES. Heparin binding to resting and activated platelets Blood 1989 ; 74 : 238-43.
26. Anderson CL, Chacko GW, Osborne JM, Brandt JT. The Fc receptor for immunoglobulin G (FcγRII) on human platelets. Semin Thromb Hemost 1995 ; 21 : 1-9.
27. Rubinstein E, Boucheix C, Worthington RE, Caroll RC. Anti-platelet antibody interactions with Fcγ receptor. Semin Thromb Hemost 1995 ; 21 : 10-22.
28. Warkentin TE, Hayward CPM, Boshkov LK, Santos AV, Sheppard JAI, Bode AP, Kelton JG. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity : an explanation for the thrombolic complications of heparin-induced thrombocytopenia. Blood 1994 ; 84 : 3691-9.
29. Monteiro RC, Kubagawa H, Cooper MD. Cellular distribution, regulation and biochemical nature of an Fcα receptor in humans. J Exp Med 1990 ; 171 : 597-613.
30. Marcus AJ, Safier LB, Broekman MJ, Islam N, Fllessbach JH, Hajjar KA, Kaminski WE, Jendraschak E, Silverstein RL, von Schacky C. Thrombosis and inflammation as multicellular processes : significance of cell-cell interactions. Thromb Haemostasis 1995 ; 74 : 213-7.
31. Nash GB. Adhesion between neutrophils and platelets : a modulator of thrombotic and inflammatory events? Thromb Res 1994 ; 74 : S3-S11.
32. Brandt E, Flad HD. Structure and function of platelet-derived cytokines of the -thromboglobulin/interleukin 8 family. Platelets 1992 ; 3 : 295-305
33. Nakamura T, Kubagawa H, Ohno T, Cooper MD. Characterization of an IgM Fc-binding receptor on human T cells. J Immunol 1993 ; 151 : 6933-41.
34. Shen L. Receptors for IgA on phagocytic cells. Immunol Res 1992 ; 11 : 273-82.
35. Cines DB, Tomaski A, Tannenbaum S. Immune endothelial-cell injury in heparin-associated thrombocytopenia. N Eng J Med 1987 ; 316 : 581-9.
36. Brandt J, Isenhgart CE, Osborne JM, Ahmed A, Anderson CL, On the role of platelet FcγRIIA phenotype in heparin-induced thrombocytopenia. Thromb Haemostasis 1995 ; 74 : 1564-72.
37. Burgess JK, Lindeman R, Chesterman CN, Chong BH. Single amino acid mutation of Fcγ receptor is associated with the development of heparin-induced thrombocytopenia. Br J Haematol 1995 ; 91 : 761-6.
38. Chong BH, Pilgrim RL, Cooley MA, Chesterman CN. Increased expression of platelet IgG Fc receptors in immune heparin induced thrombocytopenia. Blood 1993 ; 81 : 988-93.
39. Harenberg J, Malsch R, Piazolo L, Heene DL. Binding of heparin to human leukocytes. Hämostascologie 1994 ; 14 : 16-24.
40. Greinacher A, Amiral J, Dummel V, Vissac AM, Kiefel V, Mueller-Eckhardt C. Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin induced platelet activation test, and platelet factor 4/heparin enzyme linked immunosorbant assay. Transfusion 1994 ; 34 : 381-5.
41. Castaman G, Ruggeri M, Girardello R, Rodeghiero F. An unusually prolonged case of heparin-induced thrombocytopenia and disseminated intravascular coagulation. Haematologica 1992 ; 77 : 174-6.
42. Amiral J, Marfaing-Koka A, Wolf M, Alessi MC, Tardy B, Boyer-Neumann C, Vissac AM, Fressinaud E, Poncz M, Meyer D. Presence of auto-antibodies to interleukin 8 or neutrophil activating peptide-2 in patients with heparin-associated thrombocytopenia. Blood 1996 ; 88 : 410-6.
43. Bendtzen K, Hansen MB, Ross C, Poulsen LK, Svenson M. Cytokines and autoantibodies to cytokines. Cells 1995 ; 13 : 206.
44. Tanaka Y, Adams DH, Shaw S. Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol Today 1993 ; 14 : 111-5.
45. McEver RP. GMP-140 : a receptor for neutrophils and monocytes on activated platelets and endothelium. J Cell Biochem 1991 ; 45 . 150-61.
46. Aziz KA, Cawley JC, Zulel M Platelets prime PMN via released PF4 : mechanism of priming and synergy with GM-CSF. Br J Haematol 1995 ; 91 : 846-53.
47. Ramakrishna R, Manoharan A, Kwan YL, Kyle PVV Heparin-induced thrombocytopenia : cross-reactivity between standard heparin, low molecular weight heparin, dalteparin (Fragmin) and heparinoid, danaparoid (Orgaran). Br J Haematol 1995 ; 91 : 736-8.
48. Magnani HN. Heparin-induced thrombocytopenia (HIT) . an overview of 230 patients treated with orgaran (Org 10172). Thromb Haemostasis 1993 ; 70 : 554-61.
49. Boneu B, Necciari J, Cariou R, Sié P, Gabaig AM, Kieffer G, Dickinson J, Lamond G, Moelker H, Mant T, Magnani H. Pharmacokinetics and tolerance of the natural pentasaccharide (SR90107/ORG31540) with high affinity to antithrombin III in man. Thromb Haemostasis 1995 ; 74 : 1468-73.